Literature DB >> 9426328

Squamous cell carcinoma of the penis: multivariate analysis of prognostic factors and natural history in monocentric study with a conservative policy.

J C Soria1, K Fizazi, D Piron, A Kramar, A Gerbaulet, C Haie-Meder, J L Perrin, B Court, P Wibault, C Théodore.   

Abstract

BACKGROUND: Penile carcinoma is uncommon in Western countries. Here we report on a large series of patients with squamous cell carcinoma (SCC) of the penis, describing prognostic factors, survival and therapeutic results. PATIENTS AND METHODS: From 1973 to 1993, 102 patients with invasive SCC of the penis were treated at the Institut Gustave-Roussy. Precancerous lesions and conditions associated with penis cancer were analyzed retrospectively. Survival curves were estimated by the Kaplan-Meier method, and groups were compared for outcome by the log rank test for univariate comparisons and by Cox's proportional hazards model for multivariate analysis.
RESULTS: The median age at onset was 58 years. Sixty-nine patients presented with Jackson's stage I disease, 17 with stage II and 15 with stage III. The interval between the manifestation of symptoms and the diagnosis was more than a year in 13.7% of cases. Precancerous lesions were found in 17 (16.6%) patients, and a history of phimosis was noted in 25 (24.5%). In situ and invasive carcinoma were observed together in 17 (16.6%) cases and dysplasia was associated with invasive carcinoma in eight (7.8%) further cases. Conservative treatment was administered whenever feasible. Interstitial brachytherapy was performed alone or associated with limited surgery (local excision or circumcision) in 72 (70.6%) patients. Of the 28 patients with a local relapse, nine have died of their neoplasms (32%) compared to 21 of 28 patients with lymph node relapse (75%). The median follow-up was 111 months. Disease-free survival, disease-specific survival and overall survival were, respectively, 56%, 72% and 63% at five years and 42%, 66% and 50% at 10 years. Age (P = 0.01), the N status (P < 0.00001) or palpable nodes (P < 0.0038), corpus involvement (P = 0.006) and a verrucous histology (P = 0.038) had significant prognostic relevance for survival in the univariate analysis whereas the performance status, T status and Broders' grade did not. In the multivariate analysis only two parameters, involvement of the corpus (P < 0.0001) and palpable nodes (P = 0.009), were singled out as being independent variables influencing survival. A subgroup of nine patients with verrucous histologies were distinguished by their freedom from node involvement. These patients had an excellent prognosis: all are alive and disease-free. Penile integrity was preserved during follow-up in 54 patients (52.9%), 31 of whom are still alive. Of 72 patients treated by a conservative approach including brachytherapy, long-term penile integrity was maintained in 49 (68%).
CONCLUSION: Corpus involvement and clinically palpable nodes are highly statistically significant independent factors influencing overall survival. Node relapses remain a major cause of death. Thus, better management of lymph nodes is essential for improving survival even when conservative therapy is used to treat the primary.

Entities:  

Mesh:

Year:  1997        PMID: 9426328     DOI: 10.1023/a:1008248319036

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


  23 in total

Review 1.  Advanced penile cancer.

Authors:  Jonathan E Heinlen; David D Buethe; Daniel Joseph Culkin
Journal:  Int Urol Nephrol       Date:  2011-08-04       Impact factor: 2.370

Review 2.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

Review 3.  [Lymphadenectomy for penile cancer. Diagnostic and prognostic significance as well as therapeutic benefit].

Authors:  H Borchers; G Jakse
Journal:  Urologe A       Date:  2005-06       Impact factor: 0.639

4.  Non-visualization of sentinel lymph nodes in penile carcinoma.

Authors:  Bin K Kroon; Renato Valdés Olmos; Omgo E Nieweg; Simon Horenblas
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-05-05       Impact factor: 9.236

5.  Contemporary management of penile cancer including surgery and adjuvant radiotherapy: an experience in Taiwan.

Authors:  Miao-Fen Chen; Wen-Cheng Chen; Chun-Te Wu; Cheng-Keng Chuang; Kwai-Fong Ng; Joseph Tung-Chieh Chang
Journal:  World J Urol       Date:  2003-12-05       Impact factor: 4.226

Review 6.  Shortcomings of the current TNM classification for penile carcinoma: time for a change?

Authors:  Joost A P Leijte; Simon Horenblas
Journal:  World J Urol       Date:  2008-08-09       Impact factor: 4.226

Review 7.  The role of pathologic prognostic factors in squamous cell carcinoma of the penis.

Authors:  Antonio L Cubilla
Journal:  World J Urol       Date:  2008-09-03       Impact factor: 4.226

8.  The importance of microvessel density in predicting cancer progression in patients with penile squamous cell carcinoma.

Authors:  Aditi Arora; Ankur Bansal
Journal:  Int Urol Nephrol       Date:  2017-03-13       Impact factor: 2.370

9.  Radiation therapy in the management of the primary penile tumor: an update.

Authors:  Juanita Crook; Clement Ma; Laval Grimard
Journal:  World J Urol       Date:  2008-07-18       Impact factor: 4.226

10.  Reproducibility of histopathologic tumor grading in penile cancer--results of a European project.

Authors:  Ch Kakies; A Lopez-Beltran; E Comperat; A Erbersdobler; R Grobholz; O W Hakenberg; A Hartmann; L-C Horn; A K Höhn; J Köllermann; G Kristiansen; R Montironi; M Scarpelli; Ch Protzel
Journal:  Virchows Arch       Date:  2014-02-18       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.